To view the PDF file, sign up for a MySharenet subscription.

Aspen Pharmacare Holdings Limited - Trading Statement

Release Date: 21/07/2005 16:30
Code(s): APN
Wrap Text

Aspen Pharmacare Holdings Limited - Trading Statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Reg. No 1985/022935/06) Share Code: APN ISIN: ZAE000066692 Trading Statement In terms of paragraph 3.4(b) of the Listings Requirements of JSE Limited ("the JSE Listings Requirements") a listed company is required to publish a trading statement as soon as it is satisfied that a reasonable degree of certainty exists that the financial results for the period to be reported upon next will differ by at least 20% from those of the previous corresponding period. Aspen is expecting an increase of between 35% and 45% in earnings per share and between 30% and 40% in headline earnings per share for the year ended 30 June 2005 compared to those of the previous year. Headline earnings per share are adjusted to exclude the amortisation of goodwill. The anticipated higher percentage increase in earnings per share growth as compared with the percentage growth in headline earnings per share is mainly due to the adoption of accounting standard "IFRS3 (AC140) Business Combinations" for the year ended 30 June 2005. Consequently goodwill will not be amortised in Aspen"s results for the 2005 year. Aspen"s audited results for the year ended 30 June 2004 recorded goodwill amortisation of R13.8 million. The financial results on which this trading statement has been based have not been reviewed or reported on by Aspen"s external auditors. The release of the final announcement of results for the year ended 30 June 2005 is expected to be published on or about 22 August 2005. By order of the Board 21 July 2005 Sponsor: Investec Bank Limited Date: 21/07/2005 04:30:04 PM Supplied by www.sharenet.co.za Produced by the JSE SENS Department

Share This Story